ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

APGE Apogee Therapeutics Inc

50.31
-3.44 (-6.40%)
May 17 2024 - Closed
Delayed by 15 minutes

Apogee Therapeutics Financial Summary

The current APGE market cap is 2.55B. The company's latest EPS is USD -1.6580 and P/E is -30.37.

Quarter End
USD (US$)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 2023
USD (US$)
Total Revenue 0
Operating Income -93M
Net Income -83.99M
Quarter End
USD (US$)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 2023
USD (US$)
Total Assets 401.4M
Total Liabilities 21.49M
Total Equity 379.91M
Quarter End
USD (US$)
Operating
Investing
Financing
Year End December 30 2023 2023
USD (US$)
Operating -74.76M
Investing -273.91M
Financing 315.39M
Market Cap 2.55B
Price to Earnings Ratio -30.37
Price to Sales Ratio 0
Price to Cash Ratio 21.56
Price to Book Ratio 6.71
Dividend Yield -

Share Statistics

Shares Outstanding 50.66M
Average Volume (1 week) 685.14k
Average Volume (1 Month) 385.87k
52 Week Change 134.00%
52 Week High 72.29
52 Week Low 14.19
Spread (Intraday) 36.11 (71.77%)

Company Info

Company Name Apogee Therapeutics Inc
Address 1209 orange st
wilmington, delaware 19801
Website https://www.apogeetherapeutics.com
Industry biological pds,ex diagnstics (2836)